NCT04523051

Brief Summary

France and especially the region "Grand Est" have been severely impacted by the COVID-19 pandemic. The first affected patients gradually began leaving the hospitalization sector and some of them required rehabilitation before returning home. Because it has only been studied for few months, COVID 19 possible impairment remain unknown, especially in patients who required admission in ICU and needed rehabilitation. In order to better understand the impact of the disease, the investigators wish to carry out a descriptive analysis of hospitalized patient in rehabilitation center for Post-Covid-19 rehabilitation after ICU. The purpose of this study was to describe the impairments and functional independency in patients addressed to a rehabilitation center after an ICU stay for COVID 19 and to explore the factors associated with their evolution.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2020

Typical duration for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 20, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 21, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2022

Completed
Last Updated

September 22, 2022

Status Verified

September 1, 2022

Enrollment Period

1.7 years

First QC Date

August 20, 2020

Last Update Submit

September 21, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Functional Independence measure (FIM) at the admission

    The FIM is an 18-item clinician-reported scale that assesses function in six areas including self-care, continence, mobility, transfers, communication and cognition. Each of the 18 items is graded on a scale of 1-7 based on level of independence in that item (1=total assistance required, 7=complete independence).

    Day 1

  • Functional Independence measure (FIM) 1-month hospitalization

    The FIM is an 18-item clinician-reported scale that assesses function in six areas including self-care, continence, mobility, transfers, communication and cognition. Each of the 18 items is graded on a scale of 1-7 based on level of independence in that item (1=total assistance required, 7=complete independence).

    Day 30

  • Functional Independence measure (FIM) at the discharge

    The FIM is an 18-item clinician-reported scale that assesses function in six areas including self-care, continence, mobility, transfers, communication and cognition. Each of the 18 items is graded on a scale of 1-7 based on level of independence in that item (1=total assistance required, 7=complete independence).

    Day 180

Secondary Outcomes (27)

  • weight at admission

    Day 1

  • weight at the discharge

    Day 180

  • age

    Day 1

  • Estimated functional independence measure score before Covid-19

    Day 1

  • Estimated dyspnea symptoms before Covid-19

    Day 1

  • +22 more secondary outcomes

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Post-COVID patient

You may qualify if:

  • Post-COVID patient hospitalized in rehabilitation center
  • Admission in Intensive Care Unit with proven COVID-19 disease before

You may not qualify if:

  • Patients not willing to participate via using their medical files

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Etablissement de santé Filieris

Freyming-Merlebach, Moselle, 57800, France

Location

Hopital Legouest

Metz, Moselle, 57000, France

Location

CHR Metz Thionville

Metz, Moselle, 57085, France

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2020

First Posted

August 21, 2020

Study Start

April 1, 2020

Primary Completion

December 1, 2021

Study Completion

May 1, 2022

Last Updated

September 22, 2022

Record last verified: 2022-09

Locations